Affiliation:
1. Tohoku University
2. Asahikawa Medical University
3. Kyoto Prefectural University of Medicine
Abstract
Abstract
Cryptosporidium parvum is an apicomplexan parasite that causes severe zoonotic diarrhea in humans and calves. Since there are no effective treatments or vaccines for infants or immunocompromised patients, it is important to understand the molecular mechanisms of the parasite-host interaction for novel drug discovery. Mitogen-activated protein kinase (MAP kinase) is a key host factor in interactions between host and various pathogens, including parasites. Although the function of conventional MAP kinases against parasite infection has been investigated, that of atypical MAP kinases remains largely unknown. Therefore, we focused on one of the atypical MAP kinases, MAPK4, and its effect on C. parvum infection in human intestinal cells. Here, we report that MAPK4-deficient intestinal cells showed a significant reduction in C. parvum infection. We also show that host MAPK4 has a role in host cell survival from C. parvum infection. In addition, we show that C. parvum requires host MAPK4 for its successful invasion and reproduction. Taken together, our data suggest that MAPK4 is an important host factor contributing to C. parvum infection in human intestinal cells.
Publisher
Research Square Platform LLC
Reference58 articles.
1. The Biology of the Intestinal Intracellular Parasite Cryptosporidium;Guérin A;Cell Host and Microbe,2020
2. Outbreaks associated with treated recreational water — United States, 2000–2014;Hlavsa MC;American Journal of Transplantation,2018
3. Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study;Khalil IA;The Lancet Global Health,2018
4. A review of the importance of cryptosporidiosis in farm animals;Graaf DC;International Journal for Parasitology,1999
5. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study;Kotloff KL;The Lancet,2013